Cameco (CCJ) was informed by our partner, National Atomic Company Kazatomprom JSC, and Joint Venture Inkai, that the Inkai operation has resumed production. Cameco and Kazatomprom are now working with JV Inkai to determine the impact of the production suspension on the operation’s 2025 production plans. Kazatomprom holds a 60% interest in JV Inkai, while Cameco owns a 40% share.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCJ:
- Cameco Releases Updated Code of Conduct to Uphold Ethical Standards
- Cameco call volume above normal and directionally bullish
- Cameco Supports Westinghouse’s Dispute Resolution, Boosts Nuclear Industry Prospects
- Cameco’s Westinghouse resolves technology export dispute
- Cameco put volume heavy and directionally bearish